ACHE and Alzheimer disease: Given the limitations of current treatments and the urgent need to address both symptomatic relief and disease progression, researchers are continually seeking and developing potential agents that can effectively treat AD and potentially modify its course.Heterocyclic-based compounds have been reported as active inhibitors against the acetylcholinesterase enzyme (AChE).